What is it about?
It is about safety and efficacy of statins in HIV patients
Featured Image
Why is it important?
Because: it is the first comprenesive assessment of efficacy of statins in HIV patients it compares different kind of statins, confiming safety and efficacy of statins
Perspectives
It may be a starting point for: - physician to drive information for these high risk patients - researcher for further studies
Dr Fabrizio D'Ascenzo
Read the Original
This page is a summary of: Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis, European Heart Journal, February 2016, European Society of Cardiology,
DOI: 10.1093/eurheartj/ehv734.
You can read the full text:
Contributors
The following have contributed to this page
